Development of a Novel Angioplasty Catheter for Treatment of Calcified Arteries

开发用于治疗钙化动脉的新型血管成形术导管

基本信息

  • 批准号:
    MR/P026850/1
  • 负责人:
  • 金额:
    $ 120.58万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2017
  • 资助国家:
    英国
  • 起止时间:
    2017 至 无数据
  • 项目状态:
    已结题

项目摘要

Coronary artery disease is very common, has significant associated morbidity and mortality, and is frequently treated by balloon angioplasty. Coronary artery calcification is highly prevalent in coronary artery disease and poses a significant challenge to angioplasty procedures. In 2012, 1.1 million angioplasty procedures were performed in the US; 38% of which involved moderate to severe calcification. Coronary artery calcification can prevent effective coronary artery dilation during balloon angioplasty leading to incomplete expansion of coronary stents; a well-established risk factor for major adverse cardiovascular events, including stent thrombosis and restenosis. Use of higher balloon pressures to crack the calcification increases the risk of complications and damage to the artery. Extensive coronary artery calcification frequently precludes angioplasty leading to coronary artery bypass grafting; a costlier alternative. Coronary artery calcification increases in prevalence with age and in older patients in which the risks of coronary artery bypass grafting may be prohibitive. We seek to address this unmet need. We have prototyped a novel device capable of delivering impacts of variable frequency and energy to sites of calcification. Such impacts lead to micro-fractures in vascular mural calcification and subsequently enable traditional angioplasty balloon dilation and stenting techniques to proceed unhindered. The proposed solution would enable the interventional cardiologist to render angioplasty in calcified coronary arteries much more predictable and therefore safe. As a standard over-the-wire technology, little additional training would be needed and minimal procedural time required to site, deploy, activate and retreive the device. Induction of micro-fractures within the vascular mural calcium would then allow safe, predictable low-pressure vessel expansion during standard balloon dilation and subsequent stenting. This approach will also potentially allow extension of the indications for angioplasty procedures into populations where calcification is currently deemed too extensive for angioplasty, particularly in the older population where calcific disease has a high prevalence but co-morbidities preclude open heart surgery.
冠状动脉疾病非常常见,具有显著相关的发病率和死亡率,并且经常通过球囊血管成形术治疗。冠状动脉钙化在冠状动脉疾病中非常普遍,对血管成形术提出了重大挑战。2012年,美国进行了110万例血管成形术;其中38%涉及中度至重度钙化。冠状动脉钙化可阻止球囊血管成形术期间的有效冠状动脉扩张,导致冠状动脉支架不完全扩张;这是主要不良心血管事件(包括支架血栓形成和再狭窄)的公认风险因素。使用较高的球囊压力来破坏钙化会增加并发症和动脉损伤的风险。广泛的冠状动脉钙化经常妨碍血管成形术,导致冠状动脉旁路移植术;一个昂贵的替代方案。冠状动脉钙化的患病率随着年龄的增长而增加,在老年患者中,冠状动脉旁路移植术的风险可能是令人望而却步的。我们致力于满足这一未满足的需求。我们已经制作了一种新型设备的原型,能够向钙化部位提供可变频率和能量的冲击。这种冲击导致血管壁钙化中的微破裂,随后使传统的血管成形术球囊扩张和支架植入技术能够不受阻碍地进行。所提出的解决方案将使介入心脏病专家能够使钙化冠状动脉中的血管成形术更可预测,因此更安全。作为一种标准的整体交换技术,定位、展开、激活和回收器械所需的额外培训很少,手术时间也很短。然后,在血管壁钙内诱导微断裂将允许在标准球囊扩张和随后的支架植入期间安全、可预测的低压血管扩张。这种方法还可能允许将血管成形术的适应症扩展到目前认为钙化过于广泛而无法进行血管成形术的人群中,特别是在钙化疾病患病率高但合并症排除心脏直视手术的老年人群中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mohammad Reza Bahmanyar其他文献

Mohammad Reza Bahmanyar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
  • 批准号:
    82070530
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
  • 批准号:
    32002421
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
  • 批准号:
    31902347
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding The Political Representation of Men: A Novel Approach to Making Politics More Inclusive
了解男性的政治代表性:使政治更具包容性的新方法
  • 批准号:
    EP/Z000246/1
  • 财政年份:
    2025
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Research Grant
PFI-TT: A Novel Wireless Sensor for Continuous Monitoring of Patients with Chronic Diseases
PFI-TT:一种用于持续监测慢性病患者的新型无线传感器
  • 批准号:
    2345803
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Continuing Grant
NSF Postdoctoral Fellowship in Biology: Investigating a Novel Circadian Time-Keeping Mechanism Revealed by Environmental Manipulation
美国国家科学基金会生物学博士后奖学金:研究环境操纵揭示的新型昼夜节律机制
  • 批准号:
    2305609
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Fellowship Award
STTR Phase I: Innovating Micro-Light Emitting Diode (LED) Manufacturing with Novel Quantum Dot Micro-Patterning Technology
STTR 第一阶段:利用新型量子点微图案化技术创新微发光二极管 (LED) 制造
  • 批准号:
    2335283
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Standard Grant
A novel damage characterization technique based on adaptive deconvolution extraction algorithm of multivariate AE signals for accurate diagnosis of osteoarthritic knees
基于多变量 AE 信号自适应反卷积提取算法的新型损伤表征技术,用于准确诊断膝关节骨关节炎
  • 批准号:
    24K07389
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of alcoholic beverage consumption based on the quantitation of novel biomarkers
基于新型生物标志物定量的酒精饮料消费证明
  • 批准号:
    24K13564
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mathematics to underpin and drive novel inertial microfluidic technologies
数学支撑和驱动新型惯性微流体技术
  • 批准号:
    DP240101089
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Discovery Projects
A Novel Surrogate Framework for evaluating THM Properties of Bentonite
评估膨润土 THM 性能的新型替代框架
  • 批准号:
    DP240102053
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Discovery Projects
EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
  • 批准号:
    DP240102729
  • 财政年份:
    2024
  • 资助金额:
    $ 120.58万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了